Maravai LifeSciences Holdings Inc - Class A (NASDAQ: MRVI) has climbed $1.1 (3.41%) and sits at $33.31, as of 12:03:08 est on May 13.

388,881 shares exchanged hands.

The Company has risen 13.06% over the last 5 days and shares lost 11.15% over the last 30 days.

Maravai LifeSciences expects its next earnings on 2022-08-10.

For technical charts, analysis, and more on Maravai LifeSciences visit the company profile.

About Maravai LifeSciences Holdings Inc - Class A

Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and proprietary technologies. Maravai companies are global leaders in providing products and services into the fields of nucleic acid production, biologics safety testing, and protein detection to many of the world's leading biopharma, vaccine, diagnostics, and cell and gene therapy companies.

To get more information on Maravai LifeSciences Holdings Inc - Class A and to follow the company's latest updates, you can visit the company's profile page here: Maravai LifeSciences Holdings Inc - Class A's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast

Under Armour CEO Patrik Frisk To Step Down in Surprise Announcement

Target Hits 52-Week Low After Missing Badly on First Quarter Earnings

DLocal Posts Record Q1, Fifth Consecutive 100%+ Revenue Growth Quarter

Another Crypto Winter Wipes Out Billions in Market Value

Inflation + Recession = Recipe for Volatility